Business Services Industry
Public Citizen President Joan Claybrook Will Join Sabrina Johnson and SJS Foundation Founder Jean McCawley at 11 A.M. Press Conference in Gaithersburg, MD
Business Wire, Feb 16, 2005
Seven-Year-Old SJS Victim Sabrina Johnson Will Ask FDA to
Reinstate Warning Label on Children's Motrin
about Stevens-Johnson Syndrome
SJS Founder Jean McCawley Will Discuss Dramatic Rise
in Reported SJS Cases in Children
Public Citizen's Joan Claybrook Will Address the Importance
of Warning Labels, Particularly for Children's Medications
WHAT:
At 11:00 A.M. on Thursday, February 17, seven-year-old
Sabrina Brierton Johnson, of Topanga, CA, and a victim of
Stevens-Johnson Syndrome (SJS), and Mrs. Jean McCawley,
founder of the Stevens Johnson Syndrome Foundation, will hold
a joint press conference in the Lobby of the Hilton Washington
North, 620 Perry Parkway, Gaithersburg, MD. They seek the
FDA's help in reinstating a warning label on Children's Motrin
about SJS. Mrs. McCawley will discuss the dramatic rise in
reported SJS cases in children.
They will be joined by Public Citizen President Joan Claybrook
who will talk about the importance of warning labels,
particularly for children's medications, referencing the
struggle it took to put a warning label on aspirin about Reyes
Syndrome.
The press conference is being held relative to the FDA's
three-day meeting of the Arthritis Advisory Committee and the
Drug Safety and Risk Management Advisory Committee from
February 16-18, 2005 which will discuss the overall benefit to
risk considerations for COX-2 selective NSAIDS (non-steroidal
anti-inflammatory drugs) and related agents. Sabrina's
parents, Ken and Joan Brierton Johnson, and brother Travis
Johnson will attend, as well as her attorney Browne Greene
with the Santa Monica, CA law firm of Greene, Broillet, Panish
& Wheeler (www.gbpwlaw.com).
After the press conference, Sabrina Brierton Johnson will be
the first person to speak at the FDA's Open Public Hearing
segment of this meeting at approximately 1:00 P.M. in the
Ballrooms at the Hilton Washington DC North. She will ask the
FDA to reinstate a warning label about SJS that was removed in
1995 when Children's Motrin was approved for over-the-counter
sale by the FDA. On behalf of the SJS Foundation, Mrs.
McCawley, through a written statement submitted to the FDA for
this Meeting, will advocate that over-the-counter ibuprofen
require a black box warning.
WHO:
Sabrina Brierton Johnson filed a complaint for damages on
December 28, 2004 against Johnson & Johnson (NYSE:JNJ) in Los
Angeles Superior Court/Compton Division claiming that an
allergic reaction to taking Children's Motrin (Stevens-Johnson
Syndrome) caused her to become blind and photosensitive. She
claims that Defendants' failure to warn the public or educate
the medical community about the possible risk of SJS
associated with using over-the-counter Children's Motrin makes
it an unsafe product and dangerous to sell to consumers, which
is why she wants the FDA to reinstate a warning label. Sabrina
Brierton Johnson vs. Johnson & Johnson, et. al., Case Number
TC 018540.
Mrs. Jean McCawley, from Westminster, CO, has an 11-year-old
daughter, Julie, who became an SJS victim when she was only
11 months old and who is now blind as a result. Mrs. McCawley
founded the SJS Foundation (www.sjsupport.org) in 1996 to make
information about SJS more accessible to the public. She will
discuss the dramatic rise in reported SJS cases in children,
and the need to institute a Federal system to report and track
SJS cases.
Joan Claybrook is President of Public Citizen is a 30-year old
non-profit organization based in Washington, DC
(www.citizen.org) dedicated to protecting health, safety and
democracy. Public Citizen recently launched
www.worstpills.org, a drug safety web site.
WHEN:
Thursday, February 17, 2005
TIME:
11:00 A.M.: Sabrina Brierton Johnson and Mrs. Jean McCawley
will hold a joint press conference in the Lobby of the Hilton
Washington DC North.
1:00 P.M.: Sabrina Brierton Johnson will address the FDA
public meeting on NSAIDS (www.fda.gov) at the Ballrooms at the
Hilton Washington DC North. See http://www.fda.gov
NOTE: Time is approximate.
WHERE:
Hilton Washington DC North - Lobby
620 Perry Parkway
Gaithersburg, MD
COPYRIGHT 2005 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions


